Page 9 - Uphat News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Uphat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Uphat Today - Breaking & Trending Today
Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Rating) have earned a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month […] ....
Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Rating) have been assigned a consensus recommendation of “Moderate Buy” from the six ratings firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average […] ....
Even if spring weather isn t here just yet, there are a couple of suburban restaurant weeks Chicago Northwest and Rosemont popping up over the next week that are giving foodies a reason to get out of the house. ....
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Rating) was the target of a large growth in short interest in May. As of May 15th, there was short interest totalling 3,100,000 shares, a growth of 24.0% from the April 30th total of 2,500,000 shares. Approximately 15.9% of the company’s shares are short sold. Based on an average […] ....
Phathom Pharmaceuticals (NASDAQ:PHAT – Get Rating) had its target price lowered by equities researchers at The Goldman Sachs Group from $32.00 to $15.00 in a research note issued to investors on Tuesday, Stock Target Advisor reports. The firm currently has a “neutral” rating on the stock. The Goldman Sachs Group’s price objective would suggest a […] ....